JP2023529196A5 - - Google Patents
Info
- Publication number
- JP2023529196A5 JP2023529196A5 JP2022575898A JP2022575898A JP2023529196A5 JP 2023529196 A5 JP2023529196 A5 JP 2023529196A5 JP 2022575898 A JP2022575898 A JP 2022575898A JP 2022575898 A JP2022575898 A JP 2022575898A JP 2023529196 A5 JP2023529196 A5 JP 2023529196A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- administration
- composition according
- compound
- cmax
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063038664P | 2020-06-12 | 2020-06-12 | |
| US63/038,664 | 2020-06-12 | ||
| PCT/US2021/037098 WO2021252959A1 (en) | 2020-06-12 | 2021-06-11 | Sulcardine administration for treatment of acute atrial fibrillation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023529196A JP2023529196A (ja) | 2023-07-07 |
| JP2023529196A5 true JP2023529196A5 (https=) | 2024-06-18 |
Family
ID=78824214
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022575898A Pending JP2023529196A (ja) | 2020-06-12 | 2021-06-11 | 急性心房細動の治療のためのサルカルディン投与 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US11813245B2 (https=) |
| EP (1) | EP4164633A4 (https=) |
| JP (1) | JP2023529196A (https=) |
| KR (1) | KR20230024347A (https=) |
| CN (1) | CN116723836A (https=) |
| AU (1) | AU2021288056A1 (https=) |
| BR (1) | BR112022025216A2 (https=) |
| CA (1) | CA3182015A1 (https=) |
| CL (1) | CL2022003501A1 (https=) |
| CO (1) | CO2023000194A2 (https=) |
| IL (1) | IL298907A (https=) |
| MX (1) | MX2022015834A (https=) |
| PH (1) | PH12022553396A1 (https=) |
| WO (1) | WO2021252959A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL298907A (en) * | 2020-06-12 | 2023-02-01 | Huyabio Int Llc | Administering sulcardin for the treatment of acute atrial fibrillation |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1172908C (zh) * | 1999-12-10 | 2004-10-27 | 中国科学院上海药物研究所 | N-取代苄基或苯基芳香磺酰胺化合物及其用途 |
| CN1939298A (zh) | 2005-09-29 | 2007-04-04 | 中国科学院上海药物研究所 | 硫酸舒欣啶固体和靶向制剂及其制备方法 |
| EP2501381B1 (en) * | 2009-11-17 | 2017-07-26 | Huya Bioscience International LLC | Treatment of atrial fibrillation |
| EP2501380B1 (en) * | 2009-11-17 | 2016-01-27 | Huya Bioscience International LLC | Slow infusion of sulcardine and its salts |
| AU2016272089B2 (en) | 2015-06-03 | 2021-02-18 | Triastek, Inc. | Dosage forms and use thereof |
| AU2017261372B2 (en) | 2016-05-05 | 2019-02-14 | Triastek, Inc. | Controlled release dosage form |
| EP3573602A4 (en) | 2017-01-26 | 2020-09-16 | Triastek, Inc. | DOSAGE FORMS OF CONTROLLED RELEASE AT SPECIFIC GASTROINTESTINAL SITES |
| CN113453677A (zh) * | 2018-12-13 | 2021-09-28 | 沪亚生物国际有限责任公司 | 用于治疗急性心房颤动的舒卡定施用 |
| SG11202108160YA (en) * | 2019-01-29 | 2021-08-30 | Huya Bioscience International Llc | Sulcardine salts |
| IL298907A (en) * | 2020-06-12 | 2023-02-01 | Huyabio Int Llc | Administering sulcardin for the treatment of acute atrial fibrillation |
-
2021
- 2021-06-11 IL IL298907A patent/IL298907A/en unknown
- 2021-06-11 CA CA3182015A patent/CA3182015A1/en active Pending
- 2021-06-11 EP EP21823026.6A patent/EP4164633A4/en active Pending
- 2021-06-11 BR BR112022025216A patent/BR112022025216A2/pt unknown
- 2021-06-11 CN CN202180055470.6A patent/CN116723836A/zh active Pending
- 2021-06-11 MX MX2022015834A patent/MX2022015834A/es unknown
- 2021-06-11 KR KR1020237000723A patent/KR20230024347A/ko active Pending
- 2021-06-11 US US17/345,564 patent/US11813245B2/en active Active
- 2021-06-11 PH PH1/2022/553396A patent/PH12022553396A1/en unknown
- 2021-06-11 WO PCT/US2021/037098 patent/WO2021252959A1/en not_active Ceased
- 2021-06-11 AU AU2021288056A patent/AU2021288056A1/en active Pending
- 2021-06-11 JP JP2022575898A patent/JP2023529196A/ja active Pending
-
2022
- 2022-12-09 CL CL2022003501A patent/CL2022003501A1/es unknown
-
2023
- 2023-01-10 CO CONC2023/0000194A patent/CO2023000194A2/es unknown
- 2023-10-11 US US18/484,823 patent/US12465587B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102056603A (zh) | 决奈达隆用于预防持续性心房纤颤 | |
| JP2021504423A5 (https=) | ||
| JP2024540183A5 (https=) | ||
| JPS60188323A (ja) | 心筋虚血治療用医薬組成物 | |
| US12396970B2 (en) | Anti-arrhythmic compositions and methods | |
| KR102268161B1 (ko) | 빈맥성부정맥 및 고혈압의 장기 치료에서 란디오롤 하이드로클로라이드의 용도 | |
| JP2012502047A (ja) | 心房細動を治療する方法 | |
| JP2022514537A5 (https=) | ||
| JP2023529196A5 (https=) | ||
| US3922340A (en) | Pharmaceutical compositions for treating lung diseases | |
| RU2731918C2 (ru) | Хорошо растворимые в воде соли фенилалкиламина - быстродействующего блокатора кальциевых каналов и их применение | |
| CN1127336C (zh) | 肺性心病治疗剂 | |
| RU2245147C2 (ru) | Применение ингибитора вазопептидазы для лечения стенокардии | |
| JP7137852B2 (ja) | ９‐β‐Ｄ‐アラビノフラノシルヒポキサンチンによる不整脈治療 | |
| JPH0552813B2 (https=) | ||
| KR20230024347A (ko) | 급성 심방 세동의 치료를 위한 설카르딘 투여 | |
| JP4784037B2 (ja) | 塩酸ランジオロールを含有する頻脈性不整脈の治療剤 | |
| JPH10139664A (ja) | 抗不整脈薬 | |
| GRYGLEWSKI et al. | who had been treated PGI2, 24 and 48 hours after occlusion of central | |
| WO2007023775A1 (ja) | 心房細動治療剤 | |
| GB2581431A (en) | Compositions, devices, and methods for treating or preventing headaches | |
| EP2387996A1 (en) | Use of dronedarone for the preparation of a medicament for the prevention of cardiovascular events in patients with permanent atrial fibrillation | |
| HK1214511B (en) | Use of landiolol hydrochloride in the long-term treatment of tachyarrhythmias | |
| GOULD | SHARIFF,** MD, and Marguerite GIULIANI,** MD | |
| JPS645573B2 (https=) |